1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 25-hydroxycholesterol in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (25-hydroxycholesterol) | Trials (25-hydroxycholesterol) | Recent Studies (post-2010) (25-hydroxycholesterol) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 853 | 3 | 243 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | 25-hydroxycholesterol (IC50) |
---|---|---|---|
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.3 | |
Sterol regulatory element-binding protein 2 | Homo sapiens (human) | 0.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ares, M; Cercek, B; Dahlgren, B; HultgÄrdh Nilsson, A; Nilsson, J; Shah, PK; Westman, J | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 25-hydroxycholesterol
Article | Year |
---|---|
Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor.
Topics: Apolipoprotein A-I; Apoptosis; Carbon Radioisotopes; Cell Count; Cell Survival; Cells, Cultured; Cytotoxins; Dose-Response Relationship, Drug; Humans; Hydroxycholesterols; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Phospholipids; Platelet Activating Factor | 1998 |